Noel Barnard
General Counsel bei VELOXIS PHARMACEUTICALS A/S
Profil
Noel Barnard is currently working as the General Counsel & Vice President-Legal at Veloxis Pharmaceuticals A.
Previously, Noel worked as the Assistant General Counsel at Cornerstone Therapeutics, Inc. from 2013 to 2016.
Noel completed their undergraduate degree at the University of Tennessee in 2008 and graduated from UNC School of Law.
Aktive Positionen von Noel Barnard
| Unternehmen | Position | Beginn |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | General Counsel | 01.03.2016 |
Ehemalige bekannte Positionen von Noel Barnard
| Unternehmen | Position | Ende |
|---|---|---|
| CORNERSTONE THERAPEUTICS, INC. | Corporate Officer/Principal | 01.03.2016 |
Ausbildung von Noel Barnard
| University of Tennessee | Undergraduate Degree |
| UNC School of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
Cornerstone Therapeutics, Inc.
 Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cornerstone Therapeutics, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for the hospital, rare disease and adjacent specialty care settings. It acquires, develops and commercializes prescription pharmaceutical drugs. The company was founded on October 31, 2008 and is headquartered in Cary, NC. | Health Technology |
